U.S. markets closed

Elixxer Ltd. (ELIXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0094-0.0012 (-11.32%)
At close: 2:34PM EDT

Elixxer Ltd.

800 Square-Victoria
Suite 3700
Montreal, QC H4Z 1E9


IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Ferras ZaltChairman & Interim CEO110.17kN/A1963
Ms. Kym No C.M.A., CPACorp. Controller & Interim CFO134.01kN/AN/A
Mr. Guy Charette L.L.B., LL.B.Legal CouncilN/AN/A1954
Mr. Jeanne van WykVP of CommunicationsN/AN/AN/A
Mr. Daniel LubienietzkyVP of Corp. Devel.N/AN/AN/A
Mr. Richard WidmannEVP of CommercialN/AN/A1968
Mr. Michael KozubCorp. Sec.N/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. is based in Montreal, Canada.

Corporate Governance

Elixxer Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.